What are the possible causes of severe leukopenia (white blood cell count < 2,000 cells/µL)?

Causes of Severe Leukopenia (WBC < 2,000 cells/µL)

Severe leukopenia results from either decreased bone marrow production, increased peripheral destruction, or sequestration of white blood cells, with the most critical causes being chemotherapy/radiation, hematologic malignancies with marrow infiltration, autoimmune destruction, severe infections, and drug-induced bone marrow suppression.

Primary Etiologic Categories

Hematologic Malignancies and Marrow Disorders

• Acute and chronic leukemias cause leukopenia through malignant cell infiltration of bone marrow, replacing normal hematopoietic tissue 1
• Myelodysplastic syndromes (MDS) produce leukopenia from dysfunctional marrow with impaired cell production 1
• Lymphomas (particularly non-Hodgkin's lymphoma) can infiltrate marrow and cause pancytopenia 1
• Multiple myeloma creates functional immunodeficiency despite sometimes elevated total immunoglobulin levels 1

Chemotherapy and Radiation-Induced Myelosuppression

This represents the most common iatrogenic cause in cancer patients. The severity correlates with:

• Neutrophil count trajectory: Rapid decline indicates poor marrow reserve and predicts severe complications 1
• Duration of neutropenia: Prolonged periods (>7 days) dramatically increase infection risk 1
• Nadir depth: Counts <100/mcL carry 10-20% risk of bloodstream infection 1

Critical point: Patients receiving multiple chemotherapy regimens face compounding risk—nearly 90% of heavily pretreated patients with fludarabine-refractory CLL develop serious infections requiring hospitalization 1

Autoimmune and Inflammatory Conditions

Autoimmunity emerges as a surprisingly frequent cause, accounting for 53.8% of isolated leukopenia cases when including positive autoimmune markers 2. Specific associations include:

• Autoimmune thyroid disease (21.8% in non-neutropenic patients) 2
• Systemic lupus erythematosus with anti-neutrophil antibodies—can progress to life-threatening levels (as low as 50/μL) 3
• Other autoimmune/autoinflammatory diseases (17.3% of cases) 2

Drug-Induced Bone Marrow Suppression

Beyond chemotherapy, multiple medications cause severe leukopenia:

• Azathioprine: Particularly in patients with TPMT deficiency (1 in 300 people homozygous for low-activity allele) 4
• Ceftriaxone and other beta-lactams: Idiosyncratic reactions more common in elderly with comorbidities 5
• Immunosuppressants used in transplantation or autoimmune disease 1

Monitoring imperative: Weekly blood counts for first 4 weeks, then 1-3 monthly for high-risk medications 4

Severe Infections

• Viral infections: HIV, parvovirus B19 (especially in hypoplastic presentations), CMV 6
• Overwhelming bacterial sepsis: Increased peripheral utilization exceeds production 7
• COVID-19: Particularly severe in patients with underlying hematologic malignancies 8

Nutritional Deficiencies

• Vitamin B12 deficiency: Causes megaloblastic changes affecting all cell lines 2
• Folate deficiency: Similar megaloblastic picture 6
• Severe malnutrition: Common in advanced malignancy, impairs marrow function 1

Hypersplenism

Splenic sequestration from portal hypertension, infiltrative diseases, or primary splenic disorders causes peripheral cytopenias despite normal marrow production 2

Inherited Bone Marrow Failure Syndromes

In younger patients, consider:

• Fanconi anemia
• Telomere disorders
• Congenital neutropenia syndromes 6, 9

Diagnostic Approach Algorithm

Step 1: Assess acuity and infection risk

• If neutrophils <500/mcL with fever: Medical emergency—immediate broad-spectrum antibiotics before workup 10
• Infection risk correlates inversely with absolute neutrophil count, especially <100/mcL 1

Step 2: Determine if isolated leukopenia or pancytopenia

• Pancytopenia (low WBC, hemoglobin, platelets): Suggests bone marrow production failure—bone marrow examination indicated 6, 10
• Isolated leukopenia: Broader differential including peripheral destruction, autoimmunity, nutritional causes 2

Step 3: Review medication history

• Document all current and recent medications, including over-the-counter drugs
• Prior chemotherapy, radiation exposure (including radioiodine) 6
• Occupational/hobby exposures (benzene) 6

Step 4: Obtain peripheral blood smear Manual differential is essential—provides information on:

• Dysplasia suggesting MDS 10
• Blast cells indicating acute leukemia
• Morphologic abnormalities
• Actual neutrophil count verification 10

Step 5: Targeted laboratory evaluation

• Autoimmune workup: ANA, anti-neutrophil antibodies, thyroid function, rheumatologic panel 2, 3
• Nutritional: B12, folate, iron studies 6
• Infectious: HIV, parvovirus B19, hepatitis panel, CMV 6
• TPMT genotyping/activity: If on or considering azathioprine, especially with pre-existing leukopenia 4

Step 6: Bone marrow examination indications Perform when:

• Pancytopenia present
• Unexplained persistent leukopenia
• Concern for hematologic malignancy or MDS
• Dysplasia on peripheral smear 6, 10

Critical Clinical Pitfalls

Pitfall 1: Assuming all leukopenia is benign or chronic—agranulocytosis with fever requires immediate hospitalization and empiric antibiotics to reduce mortality 10

Pitfall 2: Missing autoimmune causes—over half of isolated leukopenia cases have autoimmune etiology when thoroughly investigated 2

Pitfall 3: Overlooking medication effects—even short courses of common antibiotics like ceftriaxone can cause significant leukopenia in susceptible patients 5

Pitfall 4: Inadequate monitoring of high-risk medications—azathioprine requires weekly counts initially, with TPMT assessment in patients with baseline cytopenia 4

Pitfall 5: Delaying bone marrow examination in pancytopenia—this is the definitive test for production disorders and should not be postponed when indicated 6, 10